[Source: US National Library of Medicine, full page: (LINK). Abstract, edited.]
JCI Insight. 2020 Jan 7. pii: 133653. doi: 10.1172/jci.insight.133653. [Epub ahead of print]
Reciprocal immune enhancement of dengue and Zika virus infection in human skin.
Castanha PM, Erdos G, Watkins SC, Falo LD Jr, Marques ET, Barratt-Boyes SM.
Dengue (DENV) and Zika viruses (ZIKV) are closely related mosquito-borne flaviviruses that co-circulate in tropical regions and constitute major threats to global human health. Whether preexisting immunity to one virus affects disease caused by the other during primary or secondary infections is unknown but is critical in preparing for future outbreaks and predicting vaccine safety. Using a human skin explant model, we show that DENV-3 immune sera increased recruitment and infection of Langerhans cells, macrophages and dermal dendritic cells following inoculation with DENV-2 or ZIKV. Similarly, ZIKV immune sera enhanced infection with DENV-2. Immune sera increased migration of infected Langerhans cells to dermis and emigration of infected cells out of skin. Heterotypic immune sera increased viral RNA in dermis almost tenfold and reduced the amount of virus required to infect a majority of myeloid cells by 100 to 1,000 fold. Enhancement was associated with cross-reactive IgG and induction of IL-10 expression and was mediated by both CD32 and CD64 Fcγ receptors. These findings reveal that preexisting heterotypic immunity greatly enhances DENV and ZIKV infection, replication and spread in human skin. This relevant tissue model will be valuable in assessing the efficacy and risk of dengue and Zika vaccines in humans.
KEYWORDS: Dendritic cells; Immunoglobulins; Immunology; Infectious disease; Macrophages
PMID: 31910161 DOI: 10.1172/jci.insight.133653
Keywords: Dengue fever; Zika Virus; ADE.